Comparable Efficacy Between Ongoing Versus Initiation of Antiviral Therapy at Treatment for HBV-related Hepatocellular Carcinoma

Authors :: Mi Na Kim
Beom Kyung Kim
Yun Ho Roh
Na Ryung Choi
Su Jong Yu
Seung Up Kim
Source :: Clinical Gastroenterology and Hepatology. 20:1877-1880.e3
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.
Abstract: Suppression of hepatitis B virus (HBV) replication with antiviral therapy (AVT) using nucleos(t)ide analogs reduces the risk of hepatocellular carcinoma (HCC) recurrence and prolongs survival after curative treatment.

Subjects :: Hepatitis B virus
Carcinoma, Hepatocellular
Hepatitis B, Chronic
Hepatology
Liver Neoplasms
Gastroenterology
Humans
Prognosis
Antiviral Agents

Tools